What Causes Androgenetic Alopecia in Females?

A genetically inherited sensitivity of scalp follicles to androgen hormones drives this form of thinning in women, even though most people link those hormones to male biology. The pattern shows up as a gradual widening of the part and diffuse thinning across the crown, often beginning in your late thirties or forties, though it can start earlier. You may first notice extra hairs on your pillow, then in your shower drain, and finally a scalp that catches light where it never used to.

Below, you’ll find a breakdown of the hormones, genes, and medical factors behind female pattern hair loss, then how that understanding translates into the next steps worth taking.

Female Pattern Hair Loss Starts With a Genetic Sensitivity to Androgens

Hair thinning in women almost always begins quietly. You may not catch it until your part looks wider in a mirror or a photograph. By then, the underlying biology has usually been at work for years, and the cause is a specific sensitivity in your follicles rather than stress, shampoo, or bad luck.

You inherit the predisposition from both sides of the family, which is why your mother’s hair history offers only a partial clue. A genetic predisposition to androgenetic alopecia can still produce the condition even when no close female relative is noticeably thin.

The pattern looks different from male balding

Your loss is gradual and concentrated over the crown and frontal scalp rather than the temples, and most women keep their hairline. The Ludwig Scale stages this pattern into three grades based on how visible your parting becomes, from mild thinning at Grade I to more pronounced scalp visibility at Grade III. Side-by-side photos taken under the same lighting make it easier to catch what daily memory filters out.

Track changes by photographing your part under the same bathroom light every few months. Side-by-side comparison catches what daily memory filters out.

DHT and Androgen Receptors Drive Follicle Miniaturization

Once androgens enter the picture, the next question is how a normal hormone level manages to thin your hair while leaving your sister’s untouched. The answer lives at the follicle itself, inside a molecule called dihydrotestosterone.

Dihydrotestosterone (DHT) forms when the enzyme 5-alpha reductase converts testosterone in your scalp. DHT binds to receptors in susceptible follicles, shortening the anagen growth phase with each cycle. Over time, your terminal hairs become thinner, shorter, and lighter until they resemble fine peach fuzz.

Why women rarely recede at the temples

Local aromatase activity in frontal follicles partially protects you by converting testosterone into estrogen before DHT can form. That conversion is weaker along the temples and frontal hairline in men, which is why recession shows up there in male pattern loss but rarely in female pattern loss. The diffuse crown pattern you see in women is the visible signature of this uneven hormonal geography, and it is also the reason your hairline often stays intact even as density falls behind it.

Because the pattern itself is set by androgen activity at the follicle, anything that reshapes those hormone levels can redraw its boundaries.

Hormonal Conditions That Raise Androgen Levels or Shift Their Balance

Because the underlying trigger is androgen activity at your follicle, anything that pushes those hormones up, or lowers their estrogen counterweight, can accelerate thinning that was already in motion. Mapping these shifts is often where a treatment plan becomes personal.

PCOS and insulin resistance

The leading endocrine trigger, polycystic ovary syndrome, combines elevated testosterone with insulin resistance in a single metabolic and hormonal pattern. Insulin resistance raises free testosterone by lowering sex hormone-binding globulin, leaving more hormone available to act on your follicle. Many women first learn they have PCOS only after a dermatologist investigates unexplained thinning, which is why the consultation can feel like a turning point rather than a routine check.

Menopause and the loss of estrogen protection

Falling estrogen levels during menopause strip away ovarian androgen protection, allowing miniaturization that was once subtle to become clearly visible. Thinning that seemed stable for years can accelerate during your perimenopausal transition as the androgen-to-estrogen ratio tilts. Catching the shift early gives you a wider window for treatment than waiting for a more obvious change.

Thyroid dysfunction and oral contraceptives

Thyroid disorders can amplify androgen-driven thinning even when your DHT levels appear normal, partly by shortening the growth cycle on their own. Stopping, starting, or switching oral contraceptives can shift your androgen-to-estrogen ratio and tip predisposed follicles into shedding. A change in your pill formulation is sometimes enough to reveal a latent tendency, so tracking any new shedding against recent medication changes is a useful habit.

Nutritional and Medical Factors That Worsen the Underlying Pattern

Hormones set the stage, but several common deficiencies and medications decide how fast the curtain rises. Addressing these won’t reverse your genetic miniaturization, yet they often slow it down.

Hormones set the stage, but daily inputs often determine how quickly the play unfolds.

  • Iron and ferritin: low stores deprive your follicles of the building blocks for new growth, especially during menstruation.
  • Vitamin D and protein: chronic shortfall shortens the anagen phase independently of androgens.
  • Stress: sustained cortisol can push more of your follicles into the resting telogen phase and amplify visible shedding.
  • Medications: certain antidepressants, retinoids, and blood thinners aggravate the pattern in predisposed women.
  • Traction and scarring: tight braids, weaves, or extensions add a scarring layer that compounds your diffuse thinning and is harder to reverse.

Bloodwork that includes ferritin, TSH, vitamin D, and a full androgen picture often reveals a fixable layer sitting on top of the genetic one.

How Androgenetic Alopecia Differs From Other Causes of Female Hair Loss

Getting the diagnosis right matters because the treatments are not interchangeable. Treating telogen effluvium as though it were androgenetic alopecia, or the reverse, wastes months and sometimes worsens your outcome.

ConditionPatternTimelineKey clue
Androgenetic alopeciaDiffuse thinning at the crown and frontal scalpGradual over yearsWidening part, miniaturized hairs
Telogen effluviumDiffuse shedding across the whole scalpSudden, 2-3 months after a triggerUniform loss, no pattern
Alopecia areataSmooth, round patchesSudden, may recurCoin-sized bare spots
Scarring alopeciasPatchy with redness or scalingProgressive and permanentVisible inflammation, follicle loss

Scarring alopecias in particular destroy your follicles permanently and require urgent specialist care, since every month of delay costs you density you cannot get back.

That urgency is exactly why separating androgen-driven loss from its many look-alikes comes before any treatment decision.

Diagnostic Workup and First-Line Treatment Options for Women

A clear diagnosis sets up everything that follows. The workup is mostly straightforward, and the sooner you do it, the more options remain on the table.

What a dermatologist evaluates

A dermatologist examines your Ludwig pattern, reviews menstrual and medication history, and checks for acne or excess facial hair, which signals higher circulating androgens. A pull test and a magnified scalp exam help confirm miniaturization versus breakage or shedding, and that distinction often decides whether your treatment plan focuses on hormones, nutrition, or scalp recovery.

Bloodwork that often gets skipped

Standard panels usually include testosterone, DHEA-S, SHBG, ferritin, TSH, and prolactin. Each one can surface a contributing condition that changes the approach. A ferritin under 40 ng/mL, for example, can keep your growth stalled even when androgens are well controlled, so checking the number rather than assuming “normal” is worth the extra conversation with your doctor.

Treatment options worth discussing with a specialist

  • Topical minoxidil 2% or 5%: the first-line therapy for female pattern hair loss and supported by decades of trial data.
  • Anti-androgen options: certain oral contraceptives with anti-androgenic progestins, or other hormone-modulating therapies, suit selected patients with elevated androgens.
  • Procedural support: low-level laser therapy and platelet-rich plasma are sometimes used alongside medication, though evidence varies.
  • Nutritional correction: repleting iron, vitamin D, and protein supports whatever therapy you choose.

Because every therapy interacts with your specific hormone profile, the safest path is to follow the recommendations of a dermatologist who can match the plan to your labs. Early intervention preserves your existing follicles, and miniaturized follicles that fully close cannot be regrown with medication alone.

The Big Picture

Female pattern hair loss is rarely the fault of one cause. A genetic sensitivity at your follicle meets hormonal shifts, nutritional gaps, and sometimes medications, and the visible thinning you see is the sum of all of them. Identifying each layer early gives you the widest range of options and the best chance of keeping the density you have.

FAQ

What causes androgenetic alopecia in females?

It is hereditary thinning driven by follicle sensitivity to androgens. The visible loss happens when DHT binds to your susceptible follicles and shortens their growth phase over many cycles.

Is female pattern hair loss hereditary?

Yes, you inherit the predisposition from both parents. A clear family history raises your risk, though you can develop the condition without an obvious pattern on either side.

What hormones cause hair loss in women?

Dihydrotestosterone is the main driver. Higher circulating testosterone, lower estrogen during menopause, and reduced sex hormone-binding globulin from insulin resistance can all increase its effect on your follicles.

At what age does androgenetic alopecia start in women?

Most women notice the first signs between their late thirties and fifties, but it can begin after puberty, especially when PCOS is present. Your perimenopause is a common acceleration point.

Can PCOS cause androgenetic alopecia?

Yes. PCOS raises free testosterone and lowers SHBG, which exposes your follicles to more DHT and can trigger or worsen the pattern. Treating the underlying insulin resistance often helps the hair alongside other symptoms.

How is female pattern baldness diagnosed?

A dermatologist confirms it through pattern recognition, a magnified scalp exam, and targeted bloodwork. The goal is to rule out telogen effluvium, alopecia areata, scarring alopecias, and treatable deficiencies before starting your therapy.

Staff
Staff

Our team brings together health and food enthusiasts who are passionate about discovering reliable health information, nutritious choices, and enjoyable food experiences. From everyday nutrition and healthy eating ideas to recipes, ingredients, food trends, and standout dishes, we share carefully researched and thoughtfully curated content to help readers make informed choices about what they eat and enjoy.